Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Mike R. Russell"'
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Figure 2 - PDF file 55K, Neuroblastoma tissue microarray. A tissue microarray demonstrates expression of RB in neuroblastoma that is higher in high-risk and MYCN amplified samples compared to low-risk or non-amplified samples (p = 0.03)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1a7b0802e10abd8481e62667a513487
https://doi.org/10.1158/1078-0432.22451172.v1
https://doi.org/10.1158/1078-0432.22451172.v1
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Figure 5 - PDF file 138K, CDK4/6 inhibition does not induce cytotoxicity in neuroblastoma. (A) Caspase 3/7 activation and (B) PARP cleavage were not observed in cell lines with demonstrated sensitivity to LEE011. SN38, a known cytotoxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::869048f4370f89775cf3649251c7b520
https://doi.org/10.1158/1078-0432.22451163
https://doi.org/10.1158/1078-0432.22451163
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Table 1 - PDF file 78K, Genomic aberrations in the Cyclin D/CDK4/CDK6/RB pathway occur frequently in neuroblastoma cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3cffae2b92bf2b443b4e39c6e0a821a
https://doi.org/10.1158/1078-0432.22451157.v1
https://doi.org/10.1158/1078-0432.22451157.v1
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Figure 4 - PDF file 88K, Protein level expression of FOXM1 in neuroblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802aa3ec6db98dc111986a7b1f14d7a1
https://doi.org/10.1158/1078-0432.22451166.v1
https://doi.org/10.1158/1078-0432.22451166.v1
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Figure 1 - PDF file 56K, Expression of CDK4, CDK6, CCND1, and RB1 in neuroblastoma patients. Expression analysis of neuroblastoma primary tumors demonstrates that CDK4 expression, and to a lesser extent RB1 expression, is higher in high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb93c8360adcd5d5854b3a4e47422b7
https://doi.org/10.1158/1078-0432.22451175
https://doi.org/10.1158/1078-0432.22451175
Autor:
John M. Maris, Giordano Caponigro, Malte Peters, Markus Boehm, Shiva Krupa, Kristina A. Cole, Scott Delach, Sudha Parasuraman, Sunkyu Kim, Andrew Wood, Yimei Li, Daniel Martinez, Lucy Chen, Maria Gagliardi, Matthew Tsang, Mike R. Russell, Vandana Batra, Pichai Raman, JulieAnn Rader, Lori S. Hart
Supplementary Figure S1. Neuroblastoma cell lines are sensitive to binimetinib. Supplementary Figure S2. Gene expression profiling of human neuroblastoma cell lines with regards to relative sensitivity to MEK1/2 and CDK4/6 inhibition Supplementary Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e2ea30d64011bd557c761378aa7b1d9
https://doi.org/10.1158/1078-0432.22462743.v1
https://doi.org/10.1158/1078-0432.22462743.v1
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Purpose: Neuroblastoma is a pediatric cancer that continues to exact significant morbidity and mortality. Recently, a number of cell-cycle proteins, particularly those within the Cyclin D/CDK4/CDK6/RB network, have been shown to exert oncogenic roles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b2af53b041b5d656dceef4ea08c9bf3
https://doi.org/10.1158/1078-0432.c.6522114.v1
https://doi.org/10.1158/1078-0432.c.6522114.v1
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Figure 6 - PDF file 75K, Statistical analysis of in vivo growth suppression. (A) Growth rates of BE2C, 1643, and EBC1 xenografts treated with 200 mg/kg LEE011 or vehicle, as determined by linear mixed effects analysis. (B) Summary table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72e84e267b168d9c7087d5e3547dba02
https://doi.org/10.1158/1078-0432.22451160
https://doi.org/10.1158/1078-0432.22451160
Autor:
John M. Maris, Giordano Caponigro, Malte Peters, Markus Boehm, Shiva Krupa, Kristina A. Cole, Scott Delach, Sudha Parasuraman, Sunkyu Kim, Andrew Wood, Yimei Li, Daniel Martinez, Lucy Chen, Maria Gagliardi, Matthew Tsang, Mike R. Russell, Vandana Batra, Pichai Raman, JulieAnn Rader, Lori S. Hart
Table S1. Specific mutations of genes listed in Table 1. Table S2. Foundation Medicine sequencing calls of cancer-specific gene panel. Table S3. Gene lists corresponding to microarray analysis described in Figures 1A and 1B: (A) binimetinib and (B) r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c19415239b9ec64c900152251d1a26c
https://doi.org/10.1158/1078-0432.22462746
https://doi.org/10.1158/1078-0432.22462746
Autor:
John M. Maris, Giordano Caponigro, Malte Peters, Markus Boehm, Shiva Krupa, Kristina A. Cole, Scott Delach, Sudha Parasuraman, Sunkyu Kim, Andrew Wood, Yimei Li, Daniel Martinez, Lucy Chen, Maria Gagliardi, Matthew Tsang, Mike R. Russell, Vandana Batra, Pichai Raman, JulieAnn Rader, Lori S. Hart
This document contains Supplementary information, including materials and methods as well as Figure Legends for the Supplementary Figures.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed9b0fe0a652244d31f19ec4a58a638
https://doi.org/10.1158/1078-0432.22462740
https://doi.org/10.1158/1078-0432.22462740